188 Results

People

  1. Gansbacher
    Gansbacher
  2. Welte
    Welte
  3. Dupont
    Dupont
  4. Kolitz
    Kolitz
  5. Fong
    Fong
  6. Mertelsmann
    Mertelsmann
  7. Stutman
    Stutman
  8. Fair
    Fair
  9. Gilboa
    Gilboa
  10. Heston
    Heston

Groups

  1. Department of Medicine (49)
  2. Sloan Kettering Institute Faculty (37)
  3. GSK Faculty (28)
  4. Solid Tumor Oncology Division (27)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)
  6. Hematologic Malignancies, Division of (18)
  7. Surgery (18)
  8. Center for Molecular Imaging and Biotechnology (16)
  9. Immunology Program Faculty (16)
  10. Center for Hematologic Malignancies (14)
  1. "interleukin-2"
Formats
  1. Journal Article (178)
  2. Meeting Abstract (5)
  3. Conference Paper (4)
  4. Review (1)
Groups
  1. Department of Medicine (49)
  2. Sloan Kettering Institute Faculty (37)
  3. GSK Faculty (28)
  4. Solid Tumor Oncology Division (27)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)
  6. Hematologic Malignancies, Division of (18)

More Groups

People
  1. Bernd Gansbacher (28)
  2. Karl Welte (22)
  3. Bo Dupont (12)
  4. Jonathan Kolitz (11)
  5. Osias Stutman (10)
  6. Roland Mertelsmann (10)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2017 (2)
  6. 2016 (1)

More Years

Publications
  1. Journal of Immunology (22)
  2. Cancer Research (13)
  3. Journal of Experimental Medicine (9)
  4. Cellular Immunology (8)
  5. Journal of Clinical Oncology (6)
  6. Cancer Gene Therapy (4)

More Publications

Publishers
  1. American Association for Cancer Research (22)
  2. The American Association of Immunologists, Inc (22)
  3. Elsevier Inc. (19)
  4. Nature Publishing Group (15)
  5. Springer (13)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (188)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dominant-negative mutant of c-Jun inhibits cell cycle progression during the transition of CD4-CD8- to CD4+CD8+ thymocytes
    Journal Article

    King, L. B.; Tolosa, E.; Lenczowski, J. M.; Lu, F.; Lind, E. F.; Hunziker, R.; Petrie, H. T.; Ashwell, J. D.
    International Immunology (1999)

    Fulltext@MSK | Save
  • A Phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia
    Journal Article

    Kossman, S. E.; Scheinberg, D. A.; Jurcic, J. G.; Jimenez, J.; Caron, P. C.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors
    Journal Article

    D'Angelica, M.; Karpoff, H.; Halterman, M.; Ellis, J.; Klimstra, D.; Edelstein, D.; Brownlee, M.; Federoff, H.; Fong, Y.
    Cancer Immunology, Immunotherapy (1999)

    Fulltext@MSK | Save
  • Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector
    Conference Paper

    Carew, J. F.; Federoff, H.; Halterman, M.; Kraus, D. H.; Savage, H.; Sacks, P. G.; Schantz, S. P.; Shah, J. P.; Fong, Y.
    Elsevier Inc. (1998)

    Fulltext@MSK | Save
  • Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes
    Journal Article

    Krause, A.; Guo, H. F.; Latouche, J. B.; Tan, C.; Cheung, N. K. V.; Sadelain, M.
    Journal of Experimental Medicine (1998)

    Fulltext@MSK | Save
  • CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail
    Journal Article

    King, P. D.; Sadra, A.; Teng, J. M. C.; Bell, G. M.; Dupont, B.
    International Immunology (1998)

    Fulltext@MSK | Save
  • Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma
    Journal Article

    Hirschowitz, E. A.; Leonard, S.; Song, W.; Ferris, B.; Leopold, P. L.; Lewis, J. J.; Bowne, W. B.; Wang, S.; Houghton, A. N.; Crystal, R. G.
    Gene Therapy (1998)

    Fulltext@MSK | Save
  • Cytokine response of CD4+ T cells responding to HLA class II+ melanoma
    Meeting Abstract

    Brady, M.; Lee, F.; Ree, S.; Eckles, D.; Lee, J.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma
    Journal Article

    Soiffer, R. J.; Chapman, P. B.; Murray, C.; Williams, L.; Unger, P.; Collins, H.; Houghton, A. N.; Ritz, J.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • GMCSF and IL2 secreting tumor vaccines produced by HSV-mediated gene transfer synergize with γInterferon to prevent growth of hepatic metastases
    Meeting Abstract

    Karpoff, H.; Blair, S.; Federoff, H.; Brownlee, M.; Fong, Y.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save